Flexion Therapeutics to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference
December 06 2017 - 4:30PM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that
Michael Clayman, M.D., President and Chief Executive Officer, and
Dan Deardorf, Senior Vice President, Commercial Operations, will
participate in a fireside chat at the BMO Capital Markets
Prescriptions for Success Healthcare Conference in New York City on
Thursday, December 14, 2017 at 8:30 am ET. To access the live
webcast and subsequent archived recording of the presentation,
please visit the Flexion website at
http://ir.flexiontherapeutics.com/.
About Flexion TherapeuticsFlexion Therapeutics
(Nasdaq:FLXN) is a specialty pharmaceutical company focused on the
development and commercialization of novel, local therapies for the
treatment of patients with musculoskeletal conditions, beginning
with osteoarthritis, a type of degenerative arthritis. The
company's core values are focus, ingenuity, tenacity, transparency
and fun. Flexion was named one of the Boston Business Journal's
2017 Best Places to Work and one of the Top Places to
Work in Massachusetts by The Boston Globe.
Corporate Contact:
Scott YoungSr. Director, Corporate Communications & Investor
RelationsFlexion Therapeutics, Inc.T:
781-305-7194syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Apr 2023 to Apr 2024